Background & Aim:
clamp and also blood stasis during vascular surgeries. Heparin is administered to prevent thrombosis, and aPTT (activated
Partial Thromboplastin Time) test is used to make sure of anticoagulative effect of heparin. At the end of the operation,
heparin is neutralized by protamin sulfate in some centers. In this study we assessed the necessity of aPTT and using
protamin during vascular surgeries.
Thrombosis occurs when blood comes into contact with unepithelialized surfaces after vascularPatients and Method:
were matched regarding age and underlying diseases. The subjects were monitored for vascular complications during the
first postoperative 24 hours. In group A (62 cases), aPTT was determined after 2 minutes of heparin administration but
heparin was not neutralized by protamin at the end of the operation. In group B (92 cases), aPTT was not determined after
heparin administration but heparin was neutralized by an appropriate dose of protamin at the end of the operation. To
obtain mean and frequency the data were analyzed descriptively and analytical techniques such as Chi-square and t-test
were implemented using SPSS 14.
In this case-control survey, 154 cases of vascular surgery were divided into two groups whichResults:
ischemia in 1 case (0.65%), left leg neuropathy in 1 case (0.65%), and hypotension due to protamin in 1 case (0.65%). 3
cases were from group A and 1 case was from group B. Nevertheless, the observed difference was not statistically
significant although the power was high enough (power=70%).
Vascular surgery complications were seen in 4 cases (26%): right leg embolus in 1 case (0.65%), spinalConclusion:
principles, there is no need for aPTT assessment and protamin administration. This can reduce the cost, duration and
complications of operation and prevent adverse effects of protamin.
According to our findings, it seems by applying appropriate techniques and accomplishing surgicalRights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |